Clinical Trials in Salt Lake City

Showing 5961-5980 of 16,694 trials

5-HTP and Creatine for Depression

NCT04395183

This is a three-armed clinical trial examining the effect of 5-hydroxytryptophan and creatine monohydrate as augmenting agents for the treatment of depression. Subjects will be randomized between 5-HTP + placebo, creatine + placebo, and 5-HTP + creatine, for 8 weeks. The ability of the interventions to affect biomarkers associated with depression will be assessed using brain phosphorus magnetic resonance spectroscopy, functional connectivity imaging, and plasma serotonin levels.

Major Depressive Disorder

University of Utah43 participantsStarted Mar 2021

Salt Lake City, Utah, United States

COMPLETEDNA< 1 mile

Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis

NCT01029353

This study will compare the effectiveness of two surgical procedures -laparotomy versus drainage - commonly used to treat necrotizing enterocolitis (NEC) or isolated intestinal perforations (IP) in extremely low birth weight infants (≤1,000 g). Infants diagnosed with NEC or IP requiring surgical intervention, will be recruited. Subjects will be randomized to receive either a laparotomy or peritoneal drainage. Primary outcome is impairment-free survival at 18-22 months corrected age.

Infant, NewbornInfant, Low Birth WeightInfant, Small for Gestational Age+3 more

NICHD Neonatal Research Network529 participantsStarted Jan 2010

Birmingham, Alabama, United States • Los Angeles, California, United States • Palo Alto, California, United States +19 more locations

5-HTP and Creatine for Depression

Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis

Find Trials by Condition in Salt Lake City

Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism

A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial

Lavender Essential Oil-based Product System for Sleep

Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis

Open-label, Uncontrolled Phase II Trial of Intravenous PI3K Inhibitor BAY80-6946 in Patients With Relapsed, Indolent or Aggressive Non-Hodgkin's Lymphomas

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

Belimumab Assessment of Safety in SLE

Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL

Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors

Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism

Study of VIB7734 for the Treatment of Moderate to Severely Active SLE

Oral Nutritional Supplementation in Children at Risk of Undernutrition

Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa

Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.

Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer

Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP

Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine

AI-enabled Endoscopic Prediction of Post-operative Recurrence in Crohn's Disease